Task: Answer the multiple choice question.
Query: Which drug exhibits a -8.312% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a.) COc1ccc(Cc2nc3ccc(C(=O)NCCc4cccc(C)n4)cc3o2)cc1
b.) CCCc1c(OCCCOc2ccc(OCC(=O)O)cc2)ccc(C(C)=O)c1O
c.) Cc1occc1-c1nnc(SCC(=O)N2CCCCC2)o1
d.) CC(=O)N1CCC(C(=O)NCCOc2ccc(C)cc2)CC1
Answer: c. Cc1occc1-c1nnc(SCC(=O)N2CCCCC2)o1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1occc1-c1nnc(SCC(=O)N2CCCCC2)o1
Cc1occc1-c1nnc(SCC(=O)N2CCCCC2)o1
2-[[5-(2-methylfuran-3-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]-1-piperidin-1-ylethanone